Updated Jul 16, 2026
Bodenstedt Matthias has filed 3 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $99K. Lifetime open-market sales: $3.20M.
Matthias Bodenstedt is the Chief Financial Officer of MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and joint diseases. He has been involved in the company's financial operations and has filed multiple SEC documents related to his role.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 39.1K | $22.04 | $862K |
| 2026-06-18 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 2.8K | $19.60 | $55K |
| 2026-06-18 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 15.1K | $19.68 | $297K |
| 2026-05-13 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 13.7K | $20.02 | $273K |
| 2026-04-16 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale | 2.4K | $19.56 | $47K |
| 2026-04-10 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale [10b5-1] | 1.9K | $19.51 | $38K |
| 2026-04-10 | MLTX | MoonLake Immunotherapeutics | S — Open-market sale [10b5-1] | 85.9K | $18.94 | $1.63M |
| 2026-01-09 | MLTX | MoonLake Immunotherapeutics | A — Grant or award | 354.3K | $0.00 | |
| 2025-12-22 | MLTX | MoonLake Immunotherapeutics | D — Derivative transaction | 294.5K | — | |
| 2025-12-22 | MLTX | MoonLake Immunotherapeutics | J — Other acquisition / disposition | 294.5K | — | |
| 2025-10-08 | MLTX | MoonLake Immunotherapeutics | P — Open-market purchase | 10.9K | $9.09 | $99K |
Matthias Bodenstedt is the Chief Financial Officer of MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and joint diseases. He has been involved in the company's financial operations and has filed multiple SEC documents related to his role.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($99K) and 7 open-market sales ($3.20M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bodenstedt Matthias profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.